Stockscreener 앱 받기
5.12
13.31%
-0.76
Pepgen Inc 주식(PEPG)의 최신 뉴스
PepGen (PEPG) Skyrockets 121% on Stellar Experimental Treatment Trial Results - Yahoo Finance
PepGen Inc. Announces Public Offering Agreement - TipRanks
PepGen’s stock up 120% on DM1 trial success - Yahoo Finance
PepGen Inc. (PEPG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Form 424B5 PepGen Inc. - StreetInsider
PepGen, Inc. (NASDAQ:PEPG) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
PepGen stock price target raised to $12 from $8 at H.C. Wainwright - Investing.com India
PepGen (NASDAQ:PEPG) Given New $12.00 Price Target at Stifel Nicolaus - MarketBeat
S&P 500 Falls 1%; Accenture Posts Upbeat Earnings - Benzinga
Top Biotech Stocks To Watch TodaySeptember 25th - MarketBeat
Biotech Small Caps Catch Fire On Clinical And Tech News - Finimize
PepGen Stock Skyrockets Over 110% on Breakthrough DM1 Trial Results - Tokenist
Surge in PepGen Stock: What Investors Need to Know - timothysykes.com
Why Is PepGen Stock (PEPG) Up 125% Today? - TipRanks
Unusually active option classes on open September 25th - TipRanks
Is PepGen the Next Big Investment? - StocksToTrade
PepGen (PEPG) Stock: Biotech Surges 145% on Record DM1 Treatment Results - parameter.io
Why Is PepGen Stock Soaring On ThursdayPepGen (NASDAQ:PEPG) - Benzinga
Wedbush Forecasts Strong Price Appreciation for PepGen (NASDAQ:PEPG) Stock - MarketBeat
PepGen price target raised to $9 from $7 at Wedbush - TipRanks
Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews
PepGen (NASDAQ:PEPG) Price Target Raised to $12.00 at HC Wainwright - MarketBeat
HC Wainwright & Co. Maintains PepGen (PEPG) Buy Recommendation - Nasdaq
PepGen price target raised to $12 from $8 at H.C. Wainwright - TipRanks
PepGen stock soars after reporting highest splicing correction in DM1 patients - Investing.com Canada
PepGen announces public offering of common stock and pre-funded warrants - Investing.com Nigeria
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket - Benzinga
PepGen shares more than double after muscle disease drug shows promise in trial - TradingView
PepGen Inc. Announces Positive Phase 1 Study Results - TipRanks
PepGen Prices $100 Million Stock Offering; Shares Soar Pre-Bell - MarketScreener
PepGen (PEPG) Launches $100M Stock Offering to Fund Clinical Trials - GuruFocus
IMRX Soars On Pancreatic Cancer Data, PEPG Sets DM1 Splicing Correction Record, CLPT On Watch - Nasdaq
PepGen Announces Pricing of $100 Million Public Offering - BioSpace
PepGen prices common stock offering at $3.20 per share to raise $100m - Investing.com
PepGen prices 31 million shares at $3.20 per share - MarketScreener
PepGen reports positive DM1 treatment data with 53.7% splicing correction By Investing.com - Investing.com Australia
PepGen (PEPG) Stock: Soars 119% Following Major Public Offering Proposal - parameter.io
PepGen Reports Highest Mean Splicing Correction in Myotonic Dystrophy Trial; Shares Jump After Hours - MarketScreener
PepGen reports positive DM1 treatment data with 53.7% splicing correction - Investing.com India
PepGen announces common stock offering, no amount given - TipRanks
PepGen says FREEDOM clinical study achieves all key objectives - TipRanks
PepGen Announces Proposed Public Offering - Business Wire
PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients - Business Wire
PepGen's (PEPG) Buy Rating Reiterated at Guggenheim - MarketBeat
Is PepGen Inc. reversing from oversold territory2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
Is PepGen Inc. still worth holding after the dipTrade Risk Assessment & High Conviction Buy Zone Alerts - newser.com
Is PepGen Inc. stock poised for growth2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Can trapped investors hope for a rebound in PepGen Inc.Portfolio Value Report & AI Enhanced Trading Alerts - newser.com
What data driven models say about PepGen Inc.’s futureQuarterly Investment Review & Low Drawdown Momentum Ideas - newser.com
Using Bollinger Bands to evaluate PepGen Inc.Quarterly Portfolio Review & Risk Managed Investment Strategies - newser.com
Is PepGen Inc. trending in predictive chart modelsEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
Can PepGen (NASDAQ:PEPG) Afford To Invest In Growth? - Yahoo Finance
0.91%
0.26%
자본화:
|
볼륨(24시간):